Oxycodone Hydrochloride Tablet
FDA Label NDC 0904-6966

50 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Oxycodone Hydrochloride (NDC 0904-6966). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: serious and life-threatening risks from use of oxycodone hcl, 1 indications and usage, 2.1 important dosage and administration instructions, 2.2 patient access to an opioid overdose reversal agent for the emergency treatment of opioid overdose, 2.3 initial dosage, 2.4 titration and maintenance of therapy, 2.5 safe reduction or discontinuation of oxycodone hcl tablets, 3 dosage forms and strengths, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package/Label Display Panel

MAJOR®

NDC 0904-6966-61

Unit Dose

CII

Oxycodone

Hydrochloride

Tablets, USP

5 mg

Pharmacist: Dispense with

Medication Guide

100 TABLETS (10 x 10)

Rx only

5mg Carton Label (4fb6c994 Cbd3 4d0d Bdae 505cb8082e61 01)

5mg Carton Label (4fb6c994 Cbd3 4d0d Bdae 505cb8082e61 01)

MAJOR®

NDC 0904-7180-61

Unit Dose

CII

Oxycodone

Hydrochloride

Tablets, USP

15 mg

Pharmacist: Dispense with

Medication Guide

100 TABLETS (10 x 10)

Rx only

15mg Carton Label (4fb6c994 Cbd3 4d0d Bdae 505cb8082e61 00)

15mg Carton Label (4fb6c994 Cbd3 4d0d Bdae 505cb8082e61 00)

* Please review the disclaimer below.